the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Former drug rehab warden acquitted of inmate murder

A former warden at a private drug rehabilitation centre has been freed after the High Court found the prosecution failed to prove a prima facie murder case.

ALOR SETAR: The High Court here today acquitted and discharged a former warden of a private drug rehabilitation centre on a charge of murdering an inmate four years ago.

Judge Evawani Farisyta Mohammad ordered Sidi Ahmad Amin Mamat, 50, to be freed after ruling the prosecution had failed to establish a prima facie case.

In her judgment, she said the prosecution failed to prove the injuries sustained by the deceased were caused by the accused.

The evidence raised the possibility the victim had been assaulted by other individuals at different locations, she noted.

Two traces of DNA from unknown persons were found on the deceased’s sarong, the court heard.

The judge also noted that while Sidi Ahmad Amin was charged with hitting the victim on the chest and neck, the prosecution’s own pathologist testified the cause of death was injuries to the abdominal aorta.

As a result, the court ruled the charge could not be sustained and ordered the accused to be acquitted without having to enter his defence.

Sidi Ahmad Amin was charged with murdering Umar Muhajir Ghazali at the drug rehabilitation centre in Sintok, Changlun, between 11 am and 6.30 pm on Nov 4, 2021.

The charge was framed under Section 302 of the Penal Code, which carries the death sentence or imprisonment of between 30 and 40 years and not less than 12 strokes of the cane.

Sidi Ahmad Amin was represented by lawyers Mohd Hezeri Harun and Mohd Fadhly Yaacob, while the prosecution was handled by Deputy Public Prosecutor Mohamed Shah Reza Noor Azman.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings